Method for treating pulmonary disease states in mammals by altering indigenous in vivo levels of nitric oxide

Details for Australian Patent Application No. 2002329762 (hide)

Owner Cellular Sciences, Inc.

Inventors Martin, Alain

Agent Shelston IP

Pub. Number AU-B-2002329762

PCT Number PCT/US02/26060

PCT Pub. Number WO2003/017996

Priority 60/313,872 21.08.01 US

Filing date 15 August 2002

Wipo publication date 10 March 2003

Acceptance publication date 1 March 2007

International Classifications

A61K 33/00 (2006.01) Medicinal preparations containing inorganic active ingredients

A61K 31/047 (2006.01)

A61K 31/19 (2006.01)

A61K 31/195 (2006.01)

A61K 31/198 (2006.01)

A61K 31/20 (2006.01)

A61P 11/00 (2006.01) Drugs for disorders of the respiratory system

A61P 11/06 (2006.01) Drugs for disorders of the respiratory system

A61P 31/04 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 31/10 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 31/12 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

30 January 2003 Complete Application Filed

  Priority application(s): 60/313,872 21.08.01 US

5 June 2003 Application Open to Public Inspection

  Published as AU-B-2002329762

1 March 2007 Application Accepted

  Published as AU-B-2002329762

28 June 2007 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002329763-Composition and transdermal drug delivery device

2002329761-LIPOBEADS AND THEIR PRODUCTION